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Over the past 15 years, there has been a dramatic increase in the abuse of purified cocaine
preparations throughout the industrialized world. The potential lethality of the drug is now
recognized, and a growing series ofcase reports indicate that cardiotoxicity may be an important
factor in the morbidity and mortality associated with the drug. Acute myocardial infarction is a
demonstrated risk both in subjects with and without pre-existent coronary artery disease. The
arrhythmogenic potential of cocaine is less clear and appears to have been overemphasized,
although several documented cases of ventricular arrhythmia following cocaine use have been
reported. Cardiomyopathy and myocarditis associated with cocaine havealso been described, but
an etiologic relationship is presently inferential. Based upon presumed pathophysiologic mecha-
nisms, beta adrenergic blocking agents are recommended for arrhythmias, and calcium channel
blocking agents and/or nitrates for ischemic syndromes related to cocaine. It is emphasized that
these recommendations are based upon a paucity of relevant clinical studies, and controlled
clinical trials to establish their efficacy have not been performed.
In recent years, it has become clear that cocaine represents a major long-term
hazard to the physical as well as the psychological well-being of its users. The rapid
sequence ofdeaths, during the 1970s and 1980s, ofmusicians and other entertainment
figures known to have been heavy cocaine abusers has made that fact painfully
apparent. It now seems reasonable that the conclusions drawn by Bozarth and
colleagues in their animal experiments applies equally to man as to the laboratory
rat-unlimited access to cocaine often results in an unstable pattern of massive
self-administration which is attended by a very high short-term mortality [1]. It is
noteworthy that, in Bozarth's experiments, animals given unlimited access to cocaine
had more than double the mortality ofanimals given unlimited access to heroin.
Theunexpected death in 1986 ofUniversity ofMaryland star basketball player, Len
Bias, was attributed by the Maryland medical examiner to an acute cardiac arrhyth-
mia resulting fromrecreational useofcocaine. Although thefatal sequenceofevents in
the Bias case is far from clear, this incident was widely reported in the lay press and
drew national attention to the issue of cocaine cardiotoxicity. Because it is estimated
that between five and ten million Americans use the drug with some regularity, the
issue is one ofsignificant public health importance. As its use has increased in the past
ten years, there has been a concomitant increase in emergency room visits and deaths
associated temporally with that use [2]. The degree to which cardiovascular toxicity
contributes to these events is the subject of this literature review, which focuses on a
description ofspecific clinical events and their laboratory manifestations.
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PHARMACOLOGY
Cocaine is an alkaloid of the South American shrub Erythroxylon coca which has
been extensively cultivated in the mountainous regions of Peru and Bolivia since at
least the seventh century A.D. Revered by the Incas for its psychopharmacologic
properties, it is the only known naturally occurring local anesthetic. Its use in
ophthamologic, ear, nose, and throat surgery is well known but declining, primarily
because of a perceived higher toxicity in the form of cardiac arrhythmias [3]. In
general, cocaine is well tolerated as an anesthetic agent, and clear-cut episodes of
cardiac toxicity are not well documented. It is emphasized, however, that use of
cocaine in the medical care setting is in no way comparable to "street use" in which
dosage, route of administration, level of activity, and other factors are highly variable
and uncontrolled.
Cocaine's major pharmacologic effect relative to the cardiovascular system appears
to be its inhibition ofthe re-uptake ofnorepinephrine released into the synaptic cleft by
sympathetic neurons [4]. Because re-uptake is a major route for clearance of
neurotransmitter from its active receptor sites, the result is a potentiation of the
response of sympathetically innervated organs to infused catecholamines as well as to
direct sympathetic stimulation. In vascular smooth muscle derived from the rat tail
artery, for example, addition ofcocaine to the muscle bath results in an increase in the
percentage ofmaximal contractile response seen after exposure to given concentrations
of norepinephrine (Fig. 1) or to specific rates of electrical nerve stimulation [4]. In
addition, there is experimental evidence that cocaine may, in peripheral tissues,
produce direct alpha adrenergic stimulation through release of norepinephrine stored
in sympathetic nerve terminals [5].
The importance ofthe sympathetic nervous system in the regulation ofcardiovascu-
lar hemodynamics, energetics, and electrophysiology is well established. Activation of
post-junctional alpha receptors is the major determinant of coronary and peripheral
vascular resistance. Norepinephrine-medicated cardiac beta receptors regulate heart
rate and myocardial contractility-both of which are major determinants of myocar-
dial oxygen consumption. Cardiac sympathetic innervation affects the rate of sponta-
neous depolarization (automaticity) of myocardial Purkinje fibers, the speed of
atrioventricular (AV) nodal impulse transmission, and regional myocardial repolariza-
tion (refractory periods). Sympathetic stimulation is believed to play a critical role in
the arrhythmogenic long QT interval syndromes, ventricular arrhythmias occurring
during the course of acute myocardial infarction, and sudden death related to
psychologic stress. For these reasons, the theoretical potential for a potent sympatho-
mimetic agent such as cocaine to produce untoward cardiac events is great.
In man, the acute effects of cocaine on basic cardiovascular parameters have been
studied under controlled conditions. The pattern ofresponse to intravenous, intranasal,
or inhaled "freebase" cocaine is similar. After single-dose administration, the drug
induces a dose-dependent increase in blood pressure and heart rate, which reaches a
peak within 30 minutes and dissipates within approximately one hour. The magnitude
of these effects is modest. Intranasal administration of 100 mg of cocaine (a usual
recreational dose) produces a mean heart rate increase ofabout 20 beats/minute and a
mean increase ofsystolic and diastolic blood pressure ofapproximately 20 mm Hg [6].
The effects are somewhat greater with intravenous administration, where 25-32 mg
results in an increase in heart rate ofapproximately 30 beats/minute and a 25 mm Hg
increase in blood pressure. The response to "freebase" inhalation is similar to that after
intravenous administration [7] (Fig. 2).
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Although these effects are significant and clearly serve to increase myocardial
oxygen demand, they are well within the range of physiologic changes observed in
normal man. During treadmill exercise, for example, plasma catecholamines increase
dramatically, heart rate increases of more than 50 beats/minute are expected, and
systolic blood pressures in excess of 200 mm Hg are commonly observed. These
changes regularly produce myocardial ischemia in patients with fixed obstructive
coronary lesions. Myocardial infarction and life-threatening arrhythmias are rare,
however, even in patients with far-advanced coronary artery disease.
Sympathetic activation consequent to cocaine may differ from that accompanying
exercise, however. Whereas peripheral vascular and coronary vasodilation are
expected during muscular exercise, cocaine may increase coronary vascular resistance
and reduce coronary blood flow, as was seen in one cocaine study [8]. It should be
emphasized that the effects of cocaine on coronary blood flow and other important
physiologic parameters, including peripheral vascular resistance, myocardial contrac-
tility, and electrophysiologic parameters, have not been studied in man.
CLINICAL SYNDROMES
Fatal Cocaine Poisoning
The importance ofdirect cardiotoxicity in the acute syndrome most often associated
with cocaine-induced fatality is uncertain, but it appears to be minimal. This
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syndrome, which has been labeled "cocainepoisoning," ischaracterized bygeneralized
central nervous system stimulation and includes agitation, hallucinosis, hyperthermia,
and diaphoresis [9]. Generalized seizures areprominent and usually play an important
role in producing a fatal outcome. Sinus tachycardia and hypertension are observed,
and the terminal event is often related to cardiovascular collapse. The cause of death
appears to be multifactoral and related to cardiorespiratory collapse secondary to a
combination of hyperthermia, hypoxia, acidosis, and central nervous system stimula-
tion. There is no evidence that direct cardiotoxicity is a major factor leading to
terminal hypotension which, in animal studies, does not occur if hyperthermia and
seizures are prevented.
Ventricular arrhythmias and/or asystole also occur but do so in the context of
profound metabolic acidosis secondary to prolonged seizure activity [9]. Because these
metabolic derangements may produce or exacerbate ventricular arrhythmias in any
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setting, their occurrence cannot be ascribed directly to cocaine. A contributory effect
cannot be excluded, however, on the basis of available data.
Recent animal experiments also suggest that hyperthermia and seizures, not cardiac
arrhythmias, are the major cause ofdeath after cocaine overdose. In the conscious dog,
Catravas et al. reported that continuous infusion of cocaine HCl (0.5 mg/kg/minute)
resulted in incessant tonic-clonic seizures and a progressive decline in arterial pH [5].
Heart rate and blood pressure increased progressively, and there was little change in
peripheral vascular resistance. Approximately one to two minutes prior to death, an
abrupt decline in blood pressure to zero was noted, followed by respiratory arrest.
Pre-treatment with agents which prevent the development of hyperthermia and/or
seizures was effective in preventing a fatal outcome [10]. Cardiac arrhythmias were
not observed, and pre-treatment with propranolol had no effect on survival. Although
occasional subendocardial hemorrhages were noted at autopsy, these studies do not
suggest that direct effects of cocaine on the cardiovascular system are critical in
producing the fatal syndrome.
Cardiac Arrhythmias
The arrhythmogenic potential of cocaine in man remains uncertain. Although it is
frequently stated in the medical literature that cocaine may induce a variety of
superventricular and ventricular arrhythmias, only a handful of well-documented
cases have been reported. In many instances, cardiac arrhythmias ascribed to cocaine
have occurred, as noted above, in the setting of profound metabolic derangements
resulting from generalized seizures [9]. (In the Len Bias case, a seizure accompanied
by apnea and cardiac arrest appears to have been the terminal event [ 1]. Despite the
medical examiner's subsequent statements, no evidence has been presented to suggest
that a cardiac arrhythmia was primary). Other documented arrhythmic episodes have
accompanied acute ischemic syndromes such as myocardial infarction [12] -a setting
in which fatal ventricular arrhythmias are regularly noted in the absence of drug use.
Nevertheless, because of its pharmacologic properties and ability to produce a
hypersympathetic state, it is probable that cocaine may produce or exacerbate cardiac
arrhythmias under certain circumstances. Benchimol has observed accelerated idio-
ventricular rhythm following repeated intravenous injections of cocaine [13] (Fig. 3),
and there are several case reports in which cocaine may have been the primary factor in
malignant ventricular arrhythmia production [14]. Considering its widespread use and
the fact that no arrhythmias have been noted in studies in which cocaine was
administered to healthy volunteers, its arrhythmogenic potential appears to be modest.
This conclusion must be considered preliminary, however, as systematic study of the
effects ofcocaine on cardiac electrophysiology and arrhythmia occurrence in man has
not been performed. Of particular interest, the effects of large repeated doses of
cocaine taken over periods ofdays or weeks have not been examined.
Ischemic Syndromes
Coronary ischemic syndromes have been definitely related to cocaine use and
constitute the bulk ofuntoward cardiovascular events directly attributable to the drug.
Over the past five years, approximately 20 cases of cocaine-associated myocardial
infarction have been reported [12,14-24]. In some cases, the relationship of the
ischemic event to cocaine remains uncertain. In the case reported by Schachne et al. in
a letter to the New England Journal ofMedicine [16], for example, the onset of chest
141ALAN H. GRADMAN
FIG. 3. Lead II rhythm strip showing paroxysms of wide QRS complex dysrhythmia (AIVR). A
ventricular fusion beat (second QRS complex) can be seen in the lower portion.
pain occurred fully five hours after drug ingestion. It is difficult to relate an event
occurring in this time frame to cocaine on the basis ofknown pharmacologic actions of
the drug. Nevertheless, there are well-documented cases in which chest pain has
followed immediately upon administration of cocaine. It is important to emphasize
that the occurrence of myocardial infarction after cocaine use does not appear to be
related either to dose or to route ofadministration. Instances ofmyocardial infarction
are documented in which small doses administered via the intranasal route have been
implicated.
The most dramatic instances of cocaine-associated myocardial infarction have
occurred in young individuals without fixed obstructive coronary disease. In a case
reported by Rollingher et al., a 24-year-old man presented to an emergency room
following his first exposure to intravenous cocaine [12]. Shortly after drug injection,
the patient experienced nausea, diaphoresis, and agitation. One hour later, substernal
chest pain developed, and the patient sought medical attention. Blood pressure was
160/100 mm Hg, and sinus tachycardia (168 beats per minute) was noted. Recurrent
ventricular tachycardia and ventricular fibrillation requiring resuscitation occurred.
An electrocardiogram showed ST elevation in the anterior precordial leads (Fig. 4),
and an acute anterior myocardial infarction with a peak creatine phosphokinase
elevation greater than 5,000 U/L evolved. Coronary angiography performed 12 days
following admission revealed normal coronary arteries.
At least five similar cases, all involving individuals in their twenties, have been
reported in which nosignificant coronary artery disease was demonstrable by coronary
angiography [14,15]. The pathogenesis of this syndrome has given rise to intense
speculation. The leading hypothesis is that it results from acute coronary spasm
induced by cocaine. Coronary spasm is a known precipitant of transmural ischemia,
and in some instances myocardial infarction, in patients with vasospastic (Prinzme-
tal's) angina. In most such patients, however, focal coronary spasm is usually observed
when intravenous ergonovine is administered in thecardiac catheterization laboratory.
Although ergonovinechallenge has been given toseveral patients with cocaine-induced
myocardial infarction and normal coronary arteries, induced coronary spasm has not
occurred [14]. The scientifically critical but ethically questionable human experi-
ment-rechallenge with cocaine-has not been reported, and the hypothesis that
coronary spasm istheresponsible mechanism remains unproven. Thepossibility that in
situ thrombosis alone or in conjunction with focal coronary spasm is a factor in the
pathogenesis ofthis syndrome must also be considered.
In the majority of instances, cocaine-associated myocardial ischemic syndromes
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FIG. 4. Electrocardiogram (ECG) obtained three-hours after admission, showing right bundle branch
block, right axis deviation, small Q waves in V2and V4, and marked ST segment elevation. Reproduced from
[12]. Courtesy ofCanadian Medical Association Journal.
have occurred in patients with demonstrable coronary artery disease. Such individuals
are usually somewhat older (in their thirties or forties) than the groupdiscussed above,
and many have additional coronary risk factors such as cigarette smoking. At the time
of coronary angiography, critical narrowings are noted in one or more coronary
arteries, with the majority exhibiting single-vessel disease. Thus, in these patients,
cocaine appears to play a role in precipitating an acute event but cannot be considered
exclusively responsible.
Several pathogenetic mechanisms may be invoked to explain the occurrence of
angina and infarction in patients with pre-existent coronary obstruction. As noted
previously, cocaine increases heart rate and blood pressure and so leads to a significant
augmentation in myocardial oxygen requirements. In patients with regional myocar-
dial blood flow limited by fixed coronary obstruction, this process may result in a
critical oxygen supply/demand imbalance. In addition, coronary vasospasm may play
an important ancillary role. It is now apparent that dynamic reduction in coronary
artery diameter-often at the site of an atherosclerotic plaque-is an important
precipitating or contributing factor in the development of unstable angina and acute
myocardial infarction in many patients with underlying coronary artery disease. If
cocaine proves capable of inducing localized spasm in patients with normal coronary
arteries, this effect could also be a factor in those individuals with underlying fixed
obstructive lesions.
Generalized reduction in coronary flow is another potential factor. In a study
reported by Pierre et al. in abstract form, intravenous administration ofcocaine in the
anesthetized dog produced a significant fall in coronary blood flow and an increase in
coronary vascular resistance [8]. In patients with fixed obstructive coronary disease,
an increase in myocardial oxygen demand coupled with a reduction in coronary blood
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flow wouldconstitute a potent stimulus for provoking an acute ischemicsyndrome even
in the absence of localized spasm. Again, it must be emphasized that the effects of
cocaine on coronary blood flow in man are unknown, and this mechanism is at present
hypothetical.
Cardiomyopathy and Myocarditis
Several reports have recently appeared in which cardiomyopathy has been attrib-
uted to cocaine [25]. Clearly, patients who have sustained one or more episodes of
myocardial infarction frequently develop regional wall motion abnormalities, a
reduction in left ventricular ejection fraction, and congestive heart failure. In such
patients, the cardiomyopathy produced is secondary to infarction and is termed
"ischemic cardiomyopathy." Most reported instances of cocaine-associated cardio-
myopathy fall intothis category and arenot related todirectcardiotoxicity ofthedrug.
Other case reports suggest the possibility that diffuse cardiomyopathy may result from
cocaine abuse in the absence of infarction. None are definitive. Nevertheless, it is
known that profound sympathetic stimulation may produce subendocardial necrosis in
experimental animals and, as mentioned above, such lesions are noted in dogs given
lethal intravenous infusions ofcocaine. In patients with pheochromocytoma exposed to
chronically elevated catecholamine levels, diffuse cardiomyopathy is known to occur
[26]. For these reasons, cocaine, despite the lack ofclear-cut documentation, must be
considered theoretically capable of producing the syndrome of diffuse cardiomyopa-
thy. Controlled observation ofcocaine users over time will be required to establish this
syndrome with certainty.
Recently, Isner et al. reported a caseofacute myocarditis in a 25-year-old man who
presented with chest pain, dyspnea, syncope, and complete heart block following
long-term use of "freebase" cocaine [14]. An endomyocardial biopsy demonstrated a
diffuse inflammatory cell infiltrate and foci of myocardial necrosis. The patient was
treated with prednisone and azathiaprine with resolution of the biopsy findings.
Although it is possible that this case represents cocaine-induced myocarditis, the
association must be considered inferential.
OTHER CARDIOVASCULAR SYNDROMES
Several other cardiovascular syndromes have been associated with cocaine use in
isolated case reports. In a dramatic case reported by Barth et al., rupture of the
ascending aorta occurred during cocaine intoxication [27]. At necropsy, a circumfer-
ential tear was present in the ascending aorta. The patient had a history of chronic
hypertension, and it is probable that aortic dissection occurred secondary to increases
in systemic blood pressure following cocaine use. Adrouny and Magnusson [28]
described an unusual practice adopted by some "freebase" cocaine users in which
exhaled vapors containing the drug are passed to a partner via direct mouth-to-mouth
contact. In the case reported, pneumopericardium and pneumomediastinum developed
in the 20-year-old, previously healthy man subsequent to this practice. Other similar
cases have been reported [29,30]. An episode of fatal pulmonary edema following the
use of"freebase" cocaine was described by Allred and Ewer [31].
TREATMENT
Recommendations concerning the treatment of cardiac events resulting from
cocaine are based upon fragmentary clinical data and animal studies. In the 1970s
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Rappolt et al. reported on the successful useofintravenous propranolol in patients who
became agitated following cocaine use [32]. They reported that this drug appeared to
be a specific antidote to the restlessness and mental symptoms resulting from cocaine
intoxication. As noted earlier, however, propranolol is not effective in preventing a
fatal outcome in experimental studiesoflethal cocaine poisoning [5] andis probably of
little value in case of serious overdose [33]. It should also be noted that, in one case
report, intravenous propranolol administration resulted in paradoxical hypertension in
a patient treated for presumed cocaine intoxication. Nevertheless, beta blockers are
frequently recommended for use in treating supraventricular or ventricular arrhyth-
mias in thesetting ofthe hypersympathetic state induced bycocaine. In instances, such
as acute myocardial infarction where concern exists regarding the myocardial depres-
sant effects of beta adrenergic blocking agents, use ofthe short-acting agent, esmolol,
may be advantageous.
Because coronary spasm is suspected to play a role in cocaine-induced myocardial
ischemia and infarction, nitrates and/or calcium channel blockers are logical thera-
peutic choices in patients presenting with acute myocardial ischemic syndromes in the
setting of cocaine use. Sublingual or intravenous nitroglyerin may be used, and this
agent will have the additional property of lowering elevated blood pressure, if given
parenterally. Reliefofcoronary spasm as well as blood pressure reduction might also
follow administration of sublingual nifedipine or intravenous verapamil. Care should
be taken when using the latter agent in settings in which its negative inotropic effects
might be deleterious. It is interesting that, in contrast to propranolol, concomitant
administration ofthe calcium channel blocking agent nitrendipine produced a fourfold
increase in the required lethal dose ofcocaine in the laboratory rat [34]. Prophylactic
administration of calcium channel blockers to patients with a history of cocaine-
induced coronary ischemic syndromes may prove useful in patients who cannot be
persuaded to discontinue drug use. Controlled clinical trials will be required to
substantiate the efficacy ofthese interventions.
CONCLUSION
Cocaine is widely abused throughout the industrialized world. Although well known
to produce a hypersympathetic state similar to that produced by amphetamines, its
potential forseriouscardiotoxicity hasonlyrecently beenappreciated. Itwould appear,
from the paucity of well-documented case reports, that serious cardiotoxicity is a
statistically uncommon phenomenon. Nevertheless, acute myocardial infarction is a
demonstrated risk even in subjects without pre-existent coronarydisease. Theextent to
which cocaine produces cardiac arrhythmias and direct myocardial damage is
presently uncertain. Further animal experiments, observational studies, and clinical
trials are necessary todeterminetheincidence, pathogenesis, andoptimal management
of cardiovascular reactions to cocaine. Of particular interest might be case-control
studies designed to ascertain the prevalence of ischemic heart syndromes in young
individuals who do and do not use cocaine recreationally. Additional human and
animal studies of interest would include pharmacologic studies in which cocaine is
administered in combination with other recreational drugs, including alcohol.
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